Product Information

ACYCLOVIR 5% CREAM is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $8.8478 per GM under NDC 00093363020. Its NADAC has been published 365 times since Nov 20, 2019.

FDA first approved this application on Dec 30, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the acyclovir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACYCLOVIR 5% CREAM

acyclovir
$8.8478per GM
High Outlier

Strength

50 mg/g

NDC

00093363020

Classification

Generic

Dosage Form

CREAM

Route

TOPICAL

Effective Date

10/21/2026

Active Ingredients

ACYCLOVIR

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021478

FDA Approved

12/30/2002

TE Code

AB

On Market Since

8/29/2019

Price Statistics

The NADAC for ACYCLOVIR 5% CREAM has been published 365 times since Nov 20, 2019, and over the history we have for it it has declined 93.9%. The table below summarizes its recorded NADAC range and movement.

Current price$8.8478 per GM
All-time high$144.8933 (Jan 15, 2020)
All-time low$7.9189 (Nov 20, 2024)
52-week high$11.5170
52-week low$8.8478
Median price$38.0650
Average price$51.1970
Largest weekly change+94.9% (Sep 22, 2021)
Weeks tracked365
Tracking sinceNov 20, 2019

Price History

1W

0.0%

1M

-1.6%

3M

-3.0%

6M

-23.2%

1Y

-17.4%

3Y

-59.0%

5Y

-89.3%

All

-93.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the acyclovir market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACYCLOVIR 5% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for ACYCLOVIR 5% CREAM, manufactured by Teva Pharmaceuticals USA Inc., is $8.8478 per GM (NDC 00093363020), effective Nov 11, 2026.

How has the price of ACYCLOVIR 5% CREAM changed over time?

Over the history we have for it, the NADAC for ACYCLOVIR 5% CREAM has declined 93.9%. It has been tracked across 365 weekly CMS publications since Nov 20, 2019.

What are the highest and lowest recorded NADAC prices for ACYCLOVIR 5% CREAM?

Since Nov 20, 2019, the NADAC for ACYCLOVIR 5% CREAM has ranged from a low of $7.9189 (Nov 20, 2024) to a high of $144.8933 (Jan 15, 2020), with a median of $38.0650 per GM.

Are there cheaper alternatives to ACYCLOVIR 5% CREAM?

No other NADAC-published product currently shares the active ingredient and strength of ACYCLOVIR 5% CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ACYCLOVIR 5% CREAM?

ACYCLOVIR 5% CREAM (NDC 00093363020) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.